Cathie Wood acquired 11 Million Intellia Therapeutics shares worth $234 Million. That's 1.91% of their equity portfolio (14th largest holding). The investor owns 9.75% of the outstanding Intellia Therapeutics stock. The first Intellia Therapeutics trade was made in Q4 2016. Since then Cathie Wood bought shares twenty more times and sold shares on seven occasions. The investor's estimated purchase price is $382 Million, resulting in a loss of 39%.
Moderna and Intellia have declined in the double digits over the past year.
The Motley Fool, 23 days agoCathie Wood -led ARK Investment Management raised stakes in a number of biotech companies on Wednesday with these stocks recording negative returns over the ...
Benzinga, about 1 year agoThe EV maker''s shares fell on 3rd-quarter revenue miss Check out Catherine Wood Stock Picks » Download GuruFolio Report of Catherine Wood (Updated on 10/20/...
GuruFocus, over 1 year ago